American Society of Clinical Oncology

SHERPA: White

People

  1. Keohan
    Keohan
  2. Maki
    Maki
  3. Antonescu
    Antonescu

Groups

  1. Department of Medicine (3)
  2. Sarcoma Service (3)
  3. Solid Tumor Oncology Division (3)
  4. GSK Faculty (1)
  5. Tow Center for Developmental Oncology (TCDO) (1)
Search Within
  1. "Robert Maki"
  2. "2008"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (1)
Groups
  1. Department of Medicine (3)
  2. Sarcoma Service (3)
  3. Solid Tumor Oncology Division (3)
  4. GSK Faculty (1)
  5. Tow Center for Developmental Oncology (TCDO) (1)
People
  1. Robert Maki (5)
  2. David D'Adamo (3)
  3. Mary Keohan (3)
  4. Cristina Antonescu (1)
  5. Gary Schwartz (1)
  6. Gauri Bhuchar (1)

More People

Years
  1. 2008 (5)
Publications
  1. Journal of Clinical Oncology (5)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Activity of sorafenib (SOR) in patients (pts) with imatinib (IM) and sunitinib (SU)-resistant (RES) gastrointestinal stromal tumors (GIST): A phase II trial of the University of Chicago Phase II Consortium
    Meeting Abstract

    Wiebe, L.; Kasza, K. E.; Maki, R. G.; D'Adamo, D. R.; Chow, W. A.; Wade, J. L.; Agamah, E.; Stadler, W. M.; Vokes, E. E.; Kindler, H. L.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Early metabolic response to continuous daily dosing of sunitinib in soft tissue sarcomas (STS) other than GIST using FDG-PET
    Meeting Abstract

    Van den Abbeele, A. D.; Yap, J. T.; Rastarhuyeva, I.; Akhurst, T.; Keohan, M. L.; George, S.; Bhuchar, G.; Morgan, J. A.; Demetri, G. D.; Maki, R. G.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Continuous daily dosing (CDD) of sunitinib (SU) in patients with metastatic soft tissue sarcomas (STS) other than GIST: Results of a phase II trial
    Meeting Abstract

    Keohan, M. L.; Morgan, J. A.; D'Adamo, D. R.; Harmon, D.; Butrynski, J. E.; Wagner, A. J.; Schwartz, G. K.; Maki, R. G.; Demetri, G. D.; George, S.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Updated results of a phase II study of oral multi-kinase inhibitor sorafenib in sarcomas, CTEP study #7060
    Meeting Abstract

    Maki, R. G.; Keohan, M. L.; Undevia, S. D.; Livingston, M.; Cooney, M. M.; Elias, A.; Saulle, M. F.; Wright, J. J.; D'Adamo, D. R.; Schuetze, S. M.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor
    Journal Article

    Heinrich, M. C.; Maki, R. G.; Corless, C. L.; Antonescu, C. R.; Harlow, A.; Griffith, D.; Town, A.; McKinley, A.; Ou, W. B.; Fletcher, J. A.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save